Retraction: Epithelial-Mesenchymal Transition Markers and HER3 Expression Are Predictors of Elisidepsin Treatment Response in Breast and Pancreatic Cancer Cell Lines. . PLoS One 2024;19:e0298557.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Retraction: Epithelial-Mesenchymal Transition Markers and HER3 Expression Are Predictors of Elisidepsin Treatment Response in Breast and Pancreatic Cancer Cell Lines. PLoS One 2024;19:e0298557.
PMID: 38315705